Editas Medicine Inc (EDIT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

11 HURLEY ST. CAMBRIDGE, MA 02141

Editas Medicine, Inc. provides genetic engineering services. The Company offers transformative genome editing technology to create a platform for the development of potential human therapeutics. Editas Medicine operates in the United States.

Data based on most recent fiscal year report
Market Cap1.535 Billion Shares Outstanding51.3 Million Avg Volume1.068 Million
1-Yr BETA vs S&P TR2.07 Current Ratio10.44 Quick Ratio10.44
View SEC Filings from EDIT instead.

View recent insider trading info

Funds Holding EDIT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EDIT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ROBERTSON MICHELLE CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-09 2

COLLINS CYNTHIA

  • Director
19,483 2019-12-31 5

VAISHNAW AKSHAY PRESIDENT, R&D

  • Officer
0 2019-12-23 1

FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

FLAGSHIP VENTURES FUND IV, L.P.

FLAGSHIP VENTURES FUND IV-RX, L.P.

AFEYAN NOUBAR

KANIA EDWIN M JR

  • Director
  • 10% Owner
170,629,740 2019-12-09 0

BITTERMAN KEVIN

  • Director
0 2019-11-08 0

ABRAMS JUDITH R CHIEF MEDICAL OFFICER

  • Officer
25,000 2019-10-28 2

HACK ANDREW A. F.

  • Director
7,525,000 2019-08-12 1

BOSLEY KATRINE

  • Director
0 2019-07-18 0

BORISY ALEXIS

  • Director
60,906 2019-06-27 0

HIRSCH ANDREW

  • Director
0 2019-06-12 1

HOPFIELD JESSICA

  • Director
0 2019-06-12 2

MULLEN JAMES C

  • Director
0 2019-06-12 1

SCADDEN DAVID

  • Director
0 2019-06-07 2

STARR KEVIN P

0 2019-06-05 0

GLUCKSMANN ALEXANDRA

0 2019-05-31 0

COLE DOUGLAS G.

  • Director
0 2019-05-30 0

MENDLEIN JOHN

  • Director
0 2019-05-08 0

MYER VICKESH CHIEF TECHNOLOGY OFFICER

  • Officer
0 2019-03-18 4

EK ERIC INTERIM CFO

  • Officer
0 2019-03-01 1

ALBRIGHT CHARLES CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-02-06 2

VIKING GLOBAL PERFORMANCE LLC

VIKING GLOBAL EQUITIES LP

VIKING GLOBAL EQUITIES II LP

VGE III PORTFOLIO LTD.

VIKING LONG FUND GP LLC

VIKING LONG FUND MASTER LTD.

  • 10% Owner
22,703,669 2018-10-01 0

NIKOLIC BORIS

  • Director
0 2018-06-15 0

POLARIS VENTURE MANAGEMENT CO. VI, L.L.C.

POLARIS VENTURE PARTNERS VI, L.P.

POLARIS VENTURE PARTNERS FOUNDERS' FUND VI, L.P.

  • 10% Owner
12,172,819 2018-05-29 0

FLYNN JAMES E

DEERFIELD MGMT HIF, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • Director
  • 10% Owner
  • *DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION
0 2018-03-27 0

COX GERALD FRANK CHIEF MEDICAL OFFICER

  • Officer
0 2018-02-07 0

VIKING GLOBAL INVESTORS LP

VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP

VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

VIKING GLOBAL OPPORTUNITIES GP LLC

HALVORSEN OLE ANDREAS

OTT DAVID C.

SUNDHEIM DANIEL S.

  • 10% Owner
37,231,342 2016-10-26 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

STARR KEVIN P

TEPPER ROBERT I

  • 10% Owner
3,906,176 2016-08-16 0

BNG0, LLC

  • 10% Owner
No longer subject to file 2016-02-08 0

ZHANG FENG

  • 10% Owner
480,769 2016-02-02 0

LIU DAVID R.

  • 10% Owner
480,769 2016-02-02 0

JOUNG J. KEITH

  • 10% Owner
480,769 2016-02-02 0

CHURCH GEORGE

  • 10% Owner
480,769 2016-02-02 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

ROBERTSON MICHELLE - Officer CHIEF FINANCIAL OFFICER

2020-01-09 A 20,000 a 20,000 20,000.00 direct

ROBERTSON MICHELLE - Officer CHIEF FINANCIAL OFFICER

2020-01-09 A 120,000 a 120,000 20,000.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments